ArticleMolecular cancer therapeutics2023

IMiDs Augment CD3-Bispecific Antibody-Induced CD8+ T-Cell Cytotoxicity and Expansion by Enhancing IL2 Production.

Ji Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.